A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.

Clinical trial NCT01124864 · COMPLETED

Trial details

NCT number: NCT01124864
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer

Start date: 2010-10-01
Primary completion: 2014-08-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.